Massachusetts · Regulations
958 CMR 12.00 — Drug pricing review
15 sections
15 sections
- 958 CMR 12.01Scope and Purpose
- 958 CMR 12.02Definitions
- 958 CMR 12.03Notice of Identification by the Executive Office
- 958 CMR 12.04Standard Reporting Form, Requests for Information, and Attestation Form
- 958 CMR 12.05Public Notice and Stakeholder Input
- 958 CMR 12.06Identification of a Proposed Value
- 958 CMR 12.07Identification of a Proposed Supplemental Rebate
- 958 CMR 12.08Determination of Potentially Unreasonable or Excessive Pricing
- 958 CMR 12.09Determination of Unreasonable or Excessive Pricing
- 958 CMR 12.10Further Negotiations with the Executive Office
- 958 CMR 12.11Information Provided by the Executive Office in Connection with the Referral
- 958 CMR 12.12Confidentiality
- 958 CMR 12.13Penalties
- 958 CMR 12.14Applicability to Individual Patients
- 958 CMR 12.15Severability